Centerra Gold Posts $500.3 Million Quarterly Revenue, Lowers Mount Milligan Cost Guidance
Third-quarter net earnings fell 70% against a year-earlier impairment reversal, while adjusted earnings rose 8% and buybacks hit a record.
Centerra Gold, the Toronto-based gold and copper producer, said Thursday that third-quarter revenue rose 27% to $500.3 million from $395.2 million a year earlier, and it lowered its full-year cost guidance at Mount Milligan. Net earnings fell 70% to $88.7 million, or $0.46 per share, against a year-earlier quarter that included a large impairment reversal.
Earnings fall against a year-ago one-time gain
Net earnings compare with $292.2 million in the third quarter of 2025, a period that carried a $193.5 million reversal of an earlier impairment at the Goldfield project. Stripping out items the company says are not tied to ongoing operations, adjusted net earnings rose 8% to $71.8 million, or $0.37 per share, from $66.4 million.
Adjusted EBITDA slipped 6% to $137.6 million. Free cash flow fell to $17.1 million from $98.7 million, as cash provided by operations of $143.1 million was outweighed by spending on the Thompson Creek molybdenum restart and Goldfield. Non-sustaining capital spending reached $124.8 million, up from $32.6 million.
Gold sold came to 74,387 ounces at an average realized price of $3,483 per ounce, while all-in sustaining costs on a by-product basis were $1,775 per ounce, up from $1,652. For the first nine months, revenue rose 45% to $1,427.7 million and adjusted net earnings climbed 65% to $239.3 million.
Mount Milligan's cost target drops
Centerra cut its full-year all-in sustaining cost guidance at Mount Milligan, its gold-copper mine in British Columbia, to $1,100 to $1,200 per ounce from $1,200 to $1,300. Strong copper by-product credits made the cut possible. The mine's third-quarter cost was $985 per ounce, and it produced 44,070 ounces of gold.
CEO Paul Tomory said the quarter reflected "consistent execution at our operations." Consolidated 2026 cost guidance of $1,650 to $1,750 per ounce was unchanged. The company also raised its 2026 adjusted EBITDA guidance for the Langeloth molybdenum facility to $17 million to $22 million from $7 million to $12 million, citing higher molybdenum prices.
Record buybacks and a renewal
Centerra bought back 2,584,600 shares for a record $53.0 million in the quarter, bringing repurchases to $125.2 million for the first nine months. It also declared a quarterly dividend of C$0.07 per share, totalling $9.8 million.
The current buyback program expires November 9, 2026. Subject to Toronto Stock Exchange approval, Centerra intends to renew it for the greater of 5% of issued shares or 10% of the public float. It had 193,499,721 shares outstanding as of Thursday. Total liquidity at September 30 was $998 million, made up of $398 million in cash and $600 million available under a credit facility.
Growth projects stay on schedule
Thompson Creek in Idaho remains on track for first molybdenum production in mid-2027 and within its $425 million to $450 million capital estimate, the company said. Goldfield in Nevada has all major permits for the Gemfield deposit, with first production targeted by the end of 2028. The Kemess feasibility study is due in mid-2027.
Centerra holds its third-quarter conference call Friday at 9:00 a.m. Eastern Time.
Centerra's market value stood at $4.1 billion in Thursday's session.